Japan Immunohistochemistry Market Size & Outlook
Japan immunohistochemistry market, 2018-2030 (US$M)
Related Markets
Japan immunohistochemistry market highlights
- The Japan immunohistochemistry market generated a revenue of USD 153.7 million in 2023 and is expected to reach USD 238.2 million by 2030.
- The Japan market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
- In terms of segment, antibodies was the largest revenue generating product in 2023.
- Antibodies is the most lucrative product segment registering the fastest growth during the forecast period.
Immunohistochemistry market data book summary
| Market revenue in 2023 | USD 153.7 million |
| Market revenue in 2030 | USD 238.2 million |
| Growth rate | 6.5% (CAGR from 2023 to 2030) |
| Largest segment | Antibodies |
| Fastest growing segment | Antibodies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibodies, Reagents, Equipment, Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG, Merck KGaA, Danaher Corp, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Abcam PLC, Cell Signaling Technology, Bio SB |
Other key industry trends
- In terms of revenue, Japan accounted for 6.5% of the global immunohistochemistry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan immunohistochemistry market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 228.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunohistochemistry Market Scope
Immunohistochemistry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan immunohistochemistry market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunohistochemistry market will help companies and investors design strategic landscapes.
Antibodies was the largest segment with a revenue share of 41.25% in 2023. Horizon Databook has segmented the Japan immunohistochemistry market based on antibodies, reagents, equipment, kits covering the revenue growth of each sub-segment from 2018 to 2030.
Japan was the largest market in Asia Pacific in terms of revenue share in 2019. Rising healthcare spending coupled with presence of advanced healthcare infrastructure in the country has led to the high demand for IHC in Japan.
According to National Health Expenditure 2016 data, average healthcare spending per person in Japan accounted for USD 4,519. According to WHO, in 2018, the proportional mortality rate in Japan due to cancer was 30% and cardiovascular diseases was 27%.
Hence, with growing healthcare spending, increasing prevalence of chronic diseases, and the presence of developed healthcare infrastructure, the demand for advanced IHC technologies for rapid disease diagnosis & effective drug testing is increasing.
Reasons to subscribe to Japan immunohistochemistry market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan immunohistochemistry market databook
-
Our clientele includes a mix of immunohistochemistry market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan immunohistochemistry market , including forecasts for subscribers. This country databook contains high-level insights into Japan immunohistochemistry market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan immunohistochemistry market size, by product, 2018-2030 (US$M)
Japan Immunohistochemistry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
